- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
Results
8701
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,701 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
INIT | SEK 7.40 | 10.4% | -18.7% | SEK 416.2m | SEK 22.50 | PB17x | E31.7% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$175.05 | -2.1% | 59.7% | US$54.5b | US$174.38 | PE81.7x | E46.3% | 2.1% | Diversified Financials | ||
GAU | CA$1.98 | 1.0% | 120.0% | CA$488.4m | CA$3.51 | PS2.2x | E89.3% | n/a | Materials | ||
ONON | US$59.54 | 2.7% | 103.3% | US$18.7b | US$59.72 | PE134.1x | E29.6% | n/a | Consumer Durables | ||
PRL | CA$38.11 | 3.1% | 201.3% | CA$1.4b | CA$44.28 | PE24.2x | E37.6% | 1.5% | Diversified Financials | ||
RMDA | ج.م3.49 | 4.2% | 83.7% | ج.م5.2b | ج.م5.02 | PE19.7x | E30.8% | 1.9% | Pharmaceuticals & Biotech | ||
FWRY | ج.م8.41 | 3.1% | 49.9% | ج.م28.6b | ج.م11.39 | PE23.1x | E27.4% | n/a | Diversified Financials | ||
ZVRA | US$9.40 | -0.3% | 85.8% | US$516.7m | US$20.00 | PS20.5x | E73.5% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$33.39 | -2.5% | 133.2% | US$5.0b | US$38.67 | PS18.1x | E57.0% | n/a | Pharmaceuticals & Biotech | ||
TVTX | US$19.38 | 1.7% | 161.9% | US$1.7b | US$27.40 | PS8.3x | E72.5% | n/a | Pharmaceuticals & Biotech | ||
CRDO | US$70.69 | 51.5% | 278.0% | US$7.9b | US$69.17 | PS47.8x | E63.6% | n/a | Semiconductors | ||
ALNY | US$251.84 | -0.6% | 47.8% | US$32.6b | US$298.77 | PS15.5x | E70.3% | n/a | Pharmaceuticals & Biotech | ||
AXSM | US$100.49 | 3.6% | 46.5% | US$4.8b | US$130.47 | PS14.4x | E72.7% | n/a | Pharmaceuticals & Biotech | ||
ALKT | US$38.42 | -3.2% | 60.1% | US$3.8b | US$44.30 | PS12.2x | E98.6% | n/a | Software | ||
NVDA | US$140.26 | 3.6% | 208.2% | US$3.4t | US$171.78 | PE54.5x | E25.1% | 0.03% | Semiconductors | ||
CDR | zł179.45 | 4.2% | 66.5% | zł17.9b | zł144.33 | PE40.8x | E28.6% | 0.6% | Media | ||
SRPT | US$126.01 | -3.4% | 43.0% | US$12.2b | US$183.60 | PE98.8x | E42.5% | n/a | Pharmaceuticals & Biotech | ||
EH | US$15.18 | 3.7% | -11.3% | US$989.8m | US$24.32 | PS20.1x | E81.5% | n/a | Capital Goods | ||
FND | AU$5.18 | -30.2% | 393.3% | AU$254.0m | AU$8.72 | PS3.8x | E112.9% | n/a | Diversified Financials | ||
BTR | AU$0.026 | 4.0% | 85.7% | AU$185.5m | AU$0.05 | PS175.9x | E84.6% | n/a | Materials | ||
A247540 | ₩134,100.00 | -0.8% | -55.4% | ₩13.1t | ₩160,714.29 | PS3.8x | E84.4% | 0% | Capital Goods | ||
5038 | JP¥1,893.00 | -3.6% | -1.0% | JP¥28.4b | n/a | PE39.6x | E28.7% | 0.6% | Healthcare | ||
A178320 | ₩27,550.00 | 1.5% | 48.6% | ₩1.5t | ₩39,333.33 | PE16.7x | E39.9% | 0% | Tech | ||
BOE | AU$2.66 | -6.3% | -35.9% | AU$1.1b | AU$4.34 | PE24.4x | E32.1% | n/a | Energy |